Shen J - Search Results

1

Maximizing the potential of aggressive mouse tumor models in preclinical drug testing.

Elghetany MT, Ho JM, Shi-Qi LH, Karthik S, Su JMF, Lin Q, Du Y, Shen J, Chow WY, Lau CC, Adesina A, Major A, Erdreich-Epstein A, Hui KM, Li XN, Teo WY. Elghetany MT, et al. Among authors: shen j. Sci Rep. 2021 Jun 2;11(1):11580. doi: 10.1038/s41598-021-91167-6. Sci Rep. 2021. PMID: 34079014 Free PMC article.

2

Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA.

Wong KK, Tsang YT, Shen J, Cheng RS, Chang YM, Man TK, Lau CC. Wong KK, et al. Among authors: shen j. Nucleic Acids Res. 2004 May 17;32(9):e69. doi: 10.1093/nar/gnh072. Nucleic Acids Res. 2004. PMID: 15148342 Free PMC article.

3

Expression profiles of osteosarcoma that can predict response to chemotherapy.

Man TK, Chintagumpala M, Visvanathan J, Shen J, Perlaky L, Hicks J, Johnson M, Davino N, Murray J, Helman L, Meyer W, Triche T, Wong KK, Lau CC. Man TK, et al. Among authors: shen j. Cancer Res. 2005 Sep 15;65(18):8142-50. doi: 10.1158/0008-5472.CAN-05-0985. Cancer Res. 2005. PMID: 16166288

4

Optimising the use of TRIzol-extracted proteins in surface enhanced laser desorption/ ionization (SELDI) analysis.

Man TK, Li Y, Dang TA, Shen J, Perlaky L, Lau CC. Man TK, et al. Among authors: shen j. Proteome Sci. 2006 Mar 23;4:3. doi: 10.1186/1477-5956-4-3. Proteome Sci. 2006. PMID: 16556310 Free PMC article.

5

Identification of a plasma proteomic signature to distinguish pediatric osteosarcoma from benign osteochondroma.

Li Y, Dang TA, Shen J, Perlaky L, Hicks J, Murray J, Meyer W, Chintagumpala M, Lau CC, Man TK. Li Y, et al. Among authors: shen j. Proteomics. 2006 Jun;6(11):3426-35. doi: 10.1002/pmic.200500472. Proteomics. 2006. PMID: 16673437

6

Patched haploinsufficient mouse rhabdomyosarcoma overexpress secreted phosphoprotein 1 and matrix metalloproteinases.

De Bortoli M, Castellino RC, Skapura DG, Shen JJ, Su JM, Russell HV, Hicks MJ, Man TK, Kim JY. De Bortoli M, et al. Among authors: shen jj. Eur J Cancer. 2007 May;43(8):1308-17. doi: 10.1016/j.ejca.2007.02.008. Epub 2007 Apr 30. Eur J Cancer. 2007. PMID: 17467979

7

MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression.

Ma O, Cai WW, Zender L, Dayaram T, Shen J, Herron AJ, Lowe SW, Man TK, Lau CC, Donehower LA. Ma O, et al. Among authors: shen j. Cancer Res. 2009 Mar 15;69(6):2559-67. doi: 10.1158/0008-5472.CAN-08-2929. Epub 2009 Mar 10. Cancer Res. 2009. PMID: 19276372 Free PMC article.

8

Plasma proteome predicts chemotherapy response in osteosarcoma patients.

Li Y, Dang TA, Shen J, Hicks J, Chintagumpala M, Lau CC, Man TK. Li Y, et al. Among authors: shen j. Oncol Rep. 2011 Feb;25(2):303-14. doi: 10.3892/or.2010.1111. Epub 2010 Dec 15. Oncol Rep. 2011. PMID: 21165584

9

Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model.

Rainusso N, Man TK, Lau CC, Hicks J, Shen JJ, Yu A, Wang LL, Rosen JM. Rainusso N, et al. Among authors: shen jj. Cancer Biol Ther. 2011 Aug 15;12(4):278-87. doi: 10.4161/cbt.12.4.15951. Epub 2011 Aug 15. Cancer Biol Ther. 2011. PMID: 21617384 Free PMC article.

10

A systems biology approach reveals common metastatic pathways in osteosarcoma.

Flores RJ, Li Y, Yu A, Shen J, Rao PH, Lau SS, Vannucci M, Lau CC, Man TK. Flores RJ, et al. Among authors: shen j. BMC Syst Biol. 2012 May 28;6:50. doi: 10.1186/1752-0509-6-50. BMC Syst Biol. 2012. PMID: 22640921 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19,542 results

Search Page